Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 205438
Company: AKORN
Company: AKORN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TRIFLURIDINE | TRIFLURIDINE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/28/2017 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
TRIFLURIDINE
SOLUTION/DROPS;OPHTHALMIC; 1%
TE Code = AT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| TRIFLURIDINE | TRIFLURIDINE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 205438 | AKORN |
| TRIFLURIDINE | TRIFLURIDINE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 074311 | SANDOZ INC |
| VIROPTIC | TRIFLURIDINE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 018299 | MONARCH PHARMS |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English